2004N-0330 - Joint Meeting of the Psychopharmacologic Drugs Advisory Committee and the Pediatric Advisory Committee

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC5
  



  

  

  



  

  
Submitter : 
  

  
Ms. Darcy Gruttadaro
  

  
Date & Time: 
  

  
08/30/2004 02:08:56
  



  

  
Organization : 
  

  
National Alliance for the Mentally Ill (NAMI)
  



  

  
Consumer Group
  


  

  
Category : 
  


  

  
Issue Areas/Comments 
  


  

  



  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 Please find attached the following:



NAMI Statement of Kenneth Duckworth, M.D. On Behalf of NAMI  (The National Alliance for the Mentally Ill)Before the Food and Drug Administration Psychopharmacologic Drugs Advisory Committee and the Pediatric Subcommittee of the Anti-Infective Drugs Advisory Committee September 13, 2004



The NAMI Policy Research Institute Task Force Report, "Children and Psychotropic Medications" (Please circulate to all committee members for review).



A Press Release regarding the release of the NAMI Policy Research Institute Task Force Report, "Children and Psychotropic Medications"